Recombinant interleukin-2 in metastatic renal cell carcinoma—A European multicentre phase II study-Reference-Cited by-同舟云学术

Recombinant interleukin-2 in metastatic renal cell carcinoma—A European multicentre phase II study

Published:1991-12 Issue:12 Volume:27 Page:1583-1589
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

von der Maase H.,Geertsen P.,Thatcher N.,Jasmin C.,Mercatello A.,Fosså S.D.,Symann M.,Stoter G.,Nagel G.,Israel L.,Oskam R.,Palmer P.,Franks C.R.

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin-2;Lafreniere;Cancer Res,1985

2. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2;Mulé;Science,1984

3. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2;Rosenberg;J Exp Med,1985

4. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant Interleukin-2 to patients with metastatic cancer;Rosenberg;New Engl J Med,1985

5. Antitumor response in patients with metastatic renal cell carcinoma is dependent upon regimen intensity;Bradley,1989

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in Renal Cell Carcinoma;Advances in Tumor Immunology and Immunotherapy;2013-10-03

2. Chemotherapy in metastatic renal cell carcinoma today? A systematic review;Anti-Cancer Drugs;2013-07

3. Cancer Immunotherapy;Cancer Biotherapy and Radiopharmaceuticals;2011-02

4. Renal cell carcinoma with an emphasis on drug therapy of advanced disease, part 1;American Journal of Health-System Pharmacy;2009-09-01

5. Systemic Therapy for Metastatic Renal Cell Carcinoma: Cytokines;Clinical Management of Renal Tumors;2008